2026 (4)

1. 09-25 Dosing Piperacillin-Tazobactam in Children During Surgery
2. 09-25 Population PK Models of Isoniazid: What Twelve Studies Show
3. 09-21 Wearable Data and Molecular Phenotypes: Aggregation, Diurnal Structure and Associations
4. 09-14 Untargeted Metabolomics: From Feature Table to Association List

2025 (1)

1. 08-08 Variational Autoencoder (VAE) for Model-Informed Precision Dosing and Complex Pharmacokinetic Profiles

2024 (2)

1. 02-02 Indirect Response Models: Mechanistic Framework for Delayed Pharmacodynamic Effects
2. 01-10 D-Optimal Design Optimization for Pediatric Clinical Trials

2023 (3)

1. 09-22 Monte Carlo Simulation for Model-Informed Dose Optimization
2. 06-15 Building Interactive R-Shiny Dashboards for Pharmacokinetic Simulation Visualization
3. 05-20 Exposure-Response Analysis: Linking Pharmacokinetics to Clinical Outcomes

2022 (9)

1. 11-06 Emax Model
2. 10-15 Target-Mediated Drug Disposition (TMDD) - Nonlinear Pharmacokinetics at Low Concentrations
3. 09-03 Maximum Likelihood Estimation (MLE) vs. Maximum A Posteriori (MAP)
4. 08-13 Object Oriented Programming
5. 08-03 Scatterplots with ggplot2
6. 07-12 ATAC-seq and Deep Learning in Genomics: A Reading List
7. 07-09 Basic Transcription Note
8. 07-04 Pharmacokinetic Notes for Special Populations
9. 07-03 Drug Development and Drug-Drug Interactions